NIH-funded research R01 grant

Managing nerve pain caused by chemotherapy through remote monitoring

Official title: Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy

Funded at University of Vermont & St Agric College · NIH-11124630 · Data updated 2026-11-12

This study is testing a new way to help people who have painful nerve issues after chemotherapy by using a symptom reporting tool and follow-up calls from nurses to make sure they get the support they need.

More Chemotherapy research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Vermont & St Agric College
NIH-funded
Lab location1 site (Burlington, United States)
Project startMay 6, 2021
Project endApril 30, 2027
Funding year2025
Award (this year)$1,393,948
NIH project number5R01CA247517-05
Project IDNIH-11124630 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have recently undergone chemotherapy and are experiencing symptoms of peripheral neuropathy.

Less likely to help

Patients who have not received chemotherapy or those without symptoms of peripheral neuropathy may not benefit from this research.

What this research studies

This research investigates a new care model aimed at managing chemotherapy-induced peripheral neuropathy (CIPN), a painful condition that often arises after chemotherapy treatment. It utilizes a symptom reporting tool combined with follow-up calls from nurse practitioners to monitor and address symptoms effectively. Patients will report their symptoms via phone, app, or web, allowing for timely interventions. The study aims to evaluate the effectiveness of this approach in reducing CIPN symptoms during the critical post-chemotherapy period.

Why it matters

Potential benefit: If successful, this research could significantly alleviate nerve pain for patients recovering from chemotherapy, improving their quality of life.

How similar studies have gone: Previous studies have shown success with similar approaches in managing chemotherapy-related symptoms, indicating potential for this new model.

Where this research is happening

  • University of Vermont & St Agric College
    Burlington, United States
    Active

Researchers

  • Principal investigator: Kolb, Noah Allan — University of Vermont & St Agric College
  • Study coordinator: Kolb, Noah Allan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.